Clinical Trial Update: Perioperative Ivonescimab Plus S-1 and Oxaliplatin (SOX) for Locally Advanced Gastric or GEJ Adenocarcinoma [Phase 2]

View source ↗

Summary

This ClinicalTrials.gov entry describes a Phase 2 perioperative trial of Ivonescimab plus S-1 and oxaliplatin (SOX) for locally advanced gastric or gastroesopha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Adenocarcinoma

Drugs mentioned

• Ivonescimab (AK112/SMT112)
• OXALIPLATIN (Oxaliplatin)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Sichuan University | Conditions: Gastric Cancer, RCT | Phase 2 | Status: NOT_YET_RECRUITING